Phase 2 AML, Childhood Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Acute Myeloid LeukemiaAMLAML, Childhood+1 more

Washington University School of Medicine68 enrolled1 locationNCT06158828

Recruiting

Phase 2

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Acute Myeloid LeukemiaAML, Childhood

Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683

Recruiting

Phase 2

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Relapse/RecurrenceAML, ChildhoodRefractory AML+2 more

Children's Hospital of Soochow University50 enrolled12 locationsNCT06316960